Who invested in Lupeng Pharmaceutical?
Lupeng Pharmaceutical's investors include Temasek Holdings, Lilly Asia Ventures, Kaitai Capital and Cathay Capital.
Who invested in Lupeng Pharmaceutical
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$35Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $35MNov 2022
- Investors
- 4
The rounds
- Nov 2022
Everyone who backed them
Lilly Asia VenturesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Lupeng Pharmaceutical
How much has Lupeng Pharmaceutical raised?
Lupeng Pharmaceutical has raised $35M across 1 round since 2022.
When did Lupeng Pharmaceutical last raise?
Lupeng Pharmaceutical's most recent round was a Series A of $35M in Nov 2022.
What was Lupeng Pharmaceutical's biggest round?
Its most recent round, $35M in Nov 2022, is also its largest on record.
Who backed Lupeng Pharmaceutical first?
Lupeng Pharmaceutical's first round on record, in Nov 2022, was backed by Temasek Holdings, Lilly Asia Ventures and Kaitai Capital and 1 others.
What stage is Lupeng Pharmaceutical at?
Lupeng Pharmaceutical's latest named round is a Series A, in Nov 2022.
Companies like Lupeng Pharmaceutical
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.